UBS Group’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $626K | Buy |
322,648
+211,125
| +189% | +$410K | ﹤0.01% | 4687 |
|
|
2025
Q1 | $89.2K | Buy |
111,523
+22,017
| +25% | +$17.6K | ﹤0.01% | 5858 |
|
|
2024
Q4 | $211K | Buy |
+89,506
| New | +$211K | ﹤0.01% | 5223 |
|
|
2024
Q2 | – | Sell |
-2,618
| Closed | -$4.69K | – | 8610 |
|
|
2024
Q1 | $4.69K | Buy |
+2,618
| New | +$4.69K | ﹤0.01% | 6432 |
|
|
2023
Q4 | – | Sell |
-1,693
| Closed | -$5.25K | – | 8377 |
|
|
2023
Q3 | $5.25K | Sell |
1,693
-1,644
| -49% | -$5.1K | ﹤0.01% | 6242 |
|
|
2023
Q2 | $9.51K | Buy |
3,337
+565
| +20% | +$1.61K | ﹤0.01% | 6096 |
|
|
2023
Q1 | $10.9K | Sell |
2,772
-2,413
| -47% | -$9.51K | ﹤0.01% | 6449 |
|
|
2022
Q4 | $20.5K | Buy |
5,185
+1,865
| +56% | +$7.39K | ﹤0.01% | 6449 |
|
|
2022
Q3 | $31K | Buy |
3,320
+2,304
| +227% | +$21.5K | ﹤0.01% | 5752 |
|
|
2022
Q2 | $6K | Buy |
+1,016
| New | +$6K | ﹤0.01% | 7654 |
|
|
2022
Q1 | – | Sell |
-1,031
| Closed | -$7K | – | 9428 |
|
|
2021
Q4 | $7K | Buy |
+1,031
| New | +$7K | ﹤0.01% | 8031 |
|
|
2021
Q3 | – | Sell |
-483
| Closed | -$3K | – | 8607 |
|
|
2021
Q2 | $3K | Sell |
483
-13,016
| -96% | -$80.8K | ﹤0.01% | 7709 |
|
|
2021
Q1 | $78K | Sell |
13,499
-1,147
| -8% | -$6.63K | ﹤0.01% | 5161 |
|
|
2020
Q4 | $98K | Sell |
14,646
-1,914
| -12% | -$12.8K | ﹤0.01% | 4717 |
|
|
2020
Q3 | $121K | Buy |
16,560
+3,061
| +23% | +$22.4K | ﹤0.01% | 4254 |
|
|
2020
Q2 | $51K | Hold |
13,499
| – | – | ﹤0.01% | 5003 |
|
|
2020
Q1 | $25K | Buy |
+13,499
| New | +$25K | ﹤0.01% | 5448 |
|